The effect of combination of chelating agents on the translocation of intramuscularly depostied 239Pu nitrate in the rat.
D000818:Animals; D001842:Bone and Bones / Q000378:metabolism; D002614:Chelating Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002951:Citrates / Q000008:administration & dosage; D003676:Deferoxamine / Q000008:administration & dosage; D004357:Drug Synergism; D006820:Hyaluronic Acid / Q000008:administration & dosage; D007273:Injections, Intramuscular; D007668:Kidney / Q000378:metabolism; D007773:Lactates / Q000008:administration & dosage; D008099:Liver / Q000378:metabolism; D008297:Male; D008619:Mepivacaine / Q000008:administration & dosage; D009566:Nitrates / Q000008:administration & dosage / Q000378:metabolism; D004369:Pentetic Acid / Q000008:administration & dosage; D010848:Picolinic Acids / Q000008:administration & dosage; D011005:Plutonium / Q000008:administration & dosage / Q000378:metabolism*; D011773:Pyruvates / Q000008:administration & dosage; D051381:Rats; D013644:Tartrates / Q000008:administration & dosage; D013997:Time Factors
D002614:Chelating Agents; D002951:Citrates; D007773:Lactates; D009566:Nitrates; D010848:Picolinic Acids; D011773:Pyruvates; D013644:Tartrates; D011005:Plutonium; D004369:Pentetic Acid; D006820:Hyaluronic Acid; D008619:Mepivacaine; D003676:Deferoxamine